Literature DB >> 3846883

Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease.

D Vidyasagar, H Maeta, T N Raju, E John, R Bhat, M Go, U Dahiya, Y Roberson, A Yamin, A Narula.   

Abstract

As a prelude to clinical trials with a bovine surfactant (surfactant TA), in human infants with hyaline membrane disease, pulmonary and hemodynamic changes following its instillation in premature baboons were investigated. Baboons, delivered by cesarean section at 141 +/- 3.5 days (mean +/- SD, 77% gestation), were provided with intensive care. At 2 hours of age in one group (n = 10), 100 mg/kg of surfactant TA (reconstituted bovine surfactant, Tokyo Tanabe Co., Tokyo) was instilled into the lungs. Sequential measurements and monitoring of pulmonary and hemodynamic variables were carried out in these ten baboons and in a control group of five baboons for 16 hours, at which time the experiments were electively terminated. At birth, the pulmonary compliance, findings of chest radiographs, ratio of arterial PO2 to alveolar PO2, and respirator variables needed to maintain normal blood gas and acid base status were identical in both groups and indicative of severe hyaline membrane disease. Following surfactant instillation, the treated group demonstrated a rapid increase in PO2 with significantly improved ratio of arterial PO2 to alveolar PO2 (from a mean +/- SD pretreatment value of 0.21 +/- 0.11 to 0.45 +/- 0.11 by 16 hours). Pulmonary compliance improved similarly (from pretreatment value of 0.18 +/- 0.06 mL/cm H2O/kg to 0.27 +/- 0.09 mL/cm H2O/kg). Significant reduction in respirator support variables could be achieved in all treated animals; however, in the control animals, the pulmonary status worsened as evidenced by increasing mean airway pressure and respirator variables to keep normal blood gas and acid base status, thus worsening compliance. At autopsy, pulmonary pressure-volume curves were significantly different with large hysteresis obtained in the surfactant-treated group. Although no deleterious effect on hemodynamics was noted in surfactant TA-treated animals, a large patent ductus arteriosus was demonstrated by aortography. Increased lung blood flow, probably due to a large patent ductus arteriosus flow, was demonstrated by radiolabeled microsphere technique. The physiologic significance and clinical relevance of these findings in premature baboons treated with surfactant TA are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3846883

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  10 in total

1.  Acute effects of instillation of surfactant in severe respiratory distress syndrome.

Authors:  H L Halliday; F B McCord; B G McClure; M M Reid
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

2.  Response to bovine surfactant (surfactant TA) in two different HMD models (lambs and baboons).

Authors:  H Maeta; D Vidyasagar; T Raju; R Bhat; H Matsuda
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

3.  Surfactant and patent ductus arteriosus.

Authors:  Abhay Kumar; Anil Lakkundi; Patrick J McNamara; Arvind Sehgal
Journal:  Indian J Pediatr       Date:  2010-01-20       Impact factor: 1.967

4.  In vivo distribution of human milk leucocytes after ingestion by newborn baboons.

Authors:  L Jain; D Vidyasagar; M Xanthou; V Ghai; S Shimada; M Blend
Journal:  Arch Dis Child       Date:  1989-07       Impact factor: 3.791

5.  Pulmonary haemodynamics after surfactant replacement in severe neonatal respiratory distress syndrome.

Authors:  M C Bloom; M Roques-Gineste; F Fries; M C Lelong-Tissier
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-09       Impact factor: 5.747

6.  Instillation rate effects of Exosurf on cerebral and cardiovascular haemodynamics in preterm neonates.

Authors:  E Saliba; M Nashashibi; M C Vaillant; C Nasr; J Laugier
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-11       Impact factor: 5.747

7.  Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.

Authors:  B J Stenson; R M Glover; G J Parry; R A Wilkie; I A Laing; W O Tarnow-Mordi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-01       Impact factor: 5.747

8.  Early changes in lung function and response to surfactant replacement therapy.

Authors:  A T Gibson; R A Primhak
Journal:  Eur J Pediatr       Date:  1994-07       Impact factor: 3.183

Review 9.  "Half a Century of Evolution of Neonatology: A Witness's Story" : Dr. K. C. Chaudhuri Lifetime Achievement Award Oration Delivered at AIIMS, New Delhi on 7th September 2014.

Authors:  Dharmapuri Vidyasagar
Journal:  Indian J Pediatr       Date:  2015-08-05       Impact factor: 1.967

Review 10.  Hemodynamic consequences of respiratory interventions in preterm infants.

Authors:  Arvind Sehgal; J Lauren Ruoss; Amy H Stanford; Satyan Lakshminrusimha; Patrick J McNamara
Journal:  J Perinatol       Date:  2022-06-11       Impact factor: 3.225

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.